Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy

Title
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy
Authors
Keywords
-
Journal
Cancer Immunology Research
Volume 9, Issue 5, Pages 568-582
Publisher
American Association for Cancer Research (AACR)
Online
2021-03-16
DOI
10.1158/2326-6066.cir-20-0342

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation